These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33418856)

  • 41. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs.
    Gabutti G; Franchi M; Maniscalco L; Stefanati A
    Minerva Pediatr; 2016 Jun; 68(3):213-25. PubMed ID: 27125440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Animal models of varicella zoster virus infection.
    Haberthur K; Messaoudi I
    Pathogens; 2013 May; 2(2):364-82. PubMed ID: 25437040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Varicella vaccination].
    Heidl M; Scholz H
    Padiatr Grenzgeb; 1990; 29(1):31-6. PubMed ID: 2160635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Live attenuated varicella vaccine.
    Arvin AM; Gershon AA
    Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in antibody responses in varicella, herpes zoster and after vaccination.
    Kimoto T; Kurimura T
    Arch Virol; 1979; 59(1-2):59-67. PubMed ID: 218537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postlicensure safety surveillance for varicella vaccine.
    Wise RP; Salive ME; Braun MM; Mootrey GT; Seward JF; Rider LG; Krause PR
    JAMA; 2000 Sep; 284(10):1271-9. PubMed ID: 10979114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disseminated Varicella-Zoster Virus After Vaccination in an Immunocompetent Patient.
    Scotch AH; Hoss E; Orenstein R; Budavari AI
    J Am Osteopath Assoc; 2016 Jun; 116(6):402-5. PubMed ID: 27214778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox.
    Brunell PA; Taylor-Wiedeman J; Geiser CF; Frierson L; Lydick E
    Pediatrics; 1986 Jan; 77(1):53-6. PubMed ID: 3455669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical reinfection with varicella-zoster virus.
    Gershon AA; Steinberg SP; Gelb L
    J Infect Dis; 1984 Feb; 149(2):137-42. PubMed ID: 6321605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Varicella vaccines.
    Javed S; Javed SA; Tyring SK
    Curr Opin Infect Dis; 2012 Apr; 25(2):135-40. PubMed ID: 22123665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
    Winston DJ; Mullane KM; Cornely OA; Boeckh MJ; Brown JW; Pergam SA; Trociukas I; Žák P; Craig MD; Papanicolaou GA; Velez JD; Panse J; Hurtado K; Fernsler DA; Stek JE; Pang L; Su SC; Zhao Y; Chan ISF; Kaplan SS; Parrino J; Lee I; Popmihajlov Z; Annunziato PW; Arvin A;
    Lancet; 2018 May; 391(10135):2116-2127. PubMed ID: 29856344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety of Second-Dose Single-Antigen Varicella Vaccine.
    Su JR; Leroy Z; Lewis PW; Haber P; Marin M; Leung J; Woo EJ; Shimabukuro TT
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28174201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
    Tsolia M; Gershon AA; Steinberg SP; Gelb L
    J Pediatr; 1990 Feb; 116(2):184-9. PubMed ID: 2153790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
    Henry O; Brzostek J; Czajka H; Leviniene G; Reshetko O; Gasparini R; Pazdiora P; Plesca D; Desole MG; Kevalas R; Gabutti G; Povey M; Innis B
    Vaccine; 2018 Jan; 36(3):381-387. PubMed ID: 29224964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention and treatment of VZV infections in patients with HIV.
    Gershon AA
    Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
    Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
    Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Features of Varicella-Zoster Virus Infection.
    Kennedy PGE; Gershon AA
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30400213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.